DK165249C - Imidazooe4,5-baaquinolin-2-thionderivater samt fremgangsmaade til fremstilling deraf - Google Patents

Imidazooe4,5-baaquinolin-2-thionderivater samt fremgangsmaade til fremstilling deraf

Info

Publication number
DK165249C
DK165249C DK081091A DK81091A DK165249C DK 165249 C DK165249 C DK 165249C DK 081091 A DK081091 A DK 081091A DK 81091 A DK81091 A DK 81091A DK 165249 C DK165249 C DK 165249C
Authority
DK
Denmark
Prior art keywords
imidazooe4
baaquinolin
procedures
preparing
thion derivatives
Prior art date
Application number
DK081091A
Other languages
English (en)
Other versions
DK81091A (da
DK165249B (da
DK81091D0 (da
Inventor
Nicholas A Meanwell
John J Wright
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of DK81091A publication Critical patent/DK81091A/da
Publication of DK81091D0 publication Critical patent/DK81091D0/da
Publication of DK165249B publication Critical patent/DK165249B/da
Application granted granted Critical
Publication of DK165249C publication Critical patent/DK165249C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK081091A 1985-04-25 1991-05-01 Imidazooe4,5-baaquinolin-2-thionderivater samt fremgangsmaade til fremstilling deraf DK165249C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US72686985A 1985-04-25 1985-04-25
US72686985 1985-04-25
US06/832,212 US4668686A (en) 1985-04-25 1986-02-26 Imidazoquinoline antithrombrogenic cardiotonic agents
US83221286 1986-02-26

Publications (4)

Publication Number Publication Date
DK81091A DK81091A (da) 1991-05-01
DK81091D0 DK81091D0 (da) 1991-05-01
DK165249B DK165249B (da) 1992-10-26
DK165249C true DK165249C (da) 1993-03-22

Family

ID=27111398

Family Applications (3)

Application Number Title Priority Date Filing Date
DK190986A DK164868C (da) 1985-04-25 1986-04-24 Imidazooe4,5-baaquinolin-2-on-derivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
DK080291A DK165248C (da) 1985-04-25 1991-04-30 1,3,9,9a-tetrahydro-imidazooe4,5-baaquinolin-2-oner samt fremgangsmaade til fremstilling deraf
DK081091A DK165249C (da) 1985-04-25 1991-05-01 Imidazooe4,5-baaquinolin-2-thionderivater samt fremgangsmaade til fremstilling deraf

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DK190986A DK164868C (da) 1985-04-25 1986-04-24 Imidazooe4,5-baaquinolin-2-on-derivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
DK080291A DK165248C (da) 1985-04-25 1991-04-30 1,3,9,9a-tetrahydro-imidazooe4,5-baaquinolin-2-oner samt fremgangsmaade til fremstilling deraf

Country Status (32)

Country Link
US (1) US4668686A (da)
KR (1) KR940000828B1 (da)
CN (1) CN1016175B (da)
AT (1) AT390257B (da)
AU (1) AU592983B2 (da)
BE (1) BE904671A (da)
CA (1) CA1298836C (da)
CH (1) CH675722A5 (da)
CY (1) CY1641A (da)
DE (1) DE3614132A1 (da)
DK (3) DK164868C (da)
EG (1) EG18104A (da)
ES (3) ES8708229A1 (da)
FI (1) FI83316C (da)
FR (1) FR2581065B1 (da)
GB (1) GB2174987B (da)
GR (1) GR861086B (da)
HK (1) HK64492A (da)
HU (1) HU195813B (da)
IL (1) IL78581A0 (da)
IT (1) IT1215651B (da)
LU (1) LU86406A1 (da)
MY (1) MY102086A (da)
NL (1) NL8601053A (da)
NO (1) NO163406C (da)
NZ (1) NZ215885A (da)
OA (1) OA08242A (da)
PT (1) PT82460B (da)
SE (1) SE461468B (da)
SG (1) SG29092G (da)
SU (3) SU1450746A3 (da)
YU (1) YU46054B (da)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775674A (en) * 1986-05-23 1988-10-04 Bristol-Myers Company Imidazoquinolinylether derivatives useful as phosphodiesterase and blood aggregation inhibitors
US4701459A (en) * 1986-07-08 1987-10-20 Bristol-Myers Company 7-amino-1,3-dihydro-2H-imidazo[4,5-b]quinolin 2-ones and method for inhibiting phosphodiesterase and blood platelet aggregation
US4803210A (en) * 1987-05-29 1989-02-07 Merrell Dow Pharmaceuticals Inc. Cardiotonic tricyclic oxazolones
US4743607A (en) * 1987-05-29 1988-05-10 Merrell Dow Pharmaceuticals Inc. Cardiotonic tricyclic imidazolones
US4943573A (en) * 1989-11-01 1990-07-24 Bristol-Myers Squibb Company Imidazo[4,5-b]quinolinyloxyalkanoic acid amides with enhanced water solubility
DE4035854C2 (de) * 1990-11-10 1996-10-02 Daimler Benz Ag Vorrichtung zum Fangen und Ableiten des von einem Fahrzeugrad hochgeschleuderten Spritzwassers
PH31245A (en) * 1991-10-30 1998-06-18 Janssen Pharmaceutica Nv 1,3-Dihydro-2H-imidazoÄ4,5-BÜ-quinolin-2-one derivatives.
US5158958A (en) * 1992-04-03 1992-10-27 Bristol-Myers Squibb Company Imidazo[4,5-b]quinolinyl oxy alkyl sulfonyl piperidine derivatives
US5208237A (en) * 1992-04-03 1993-05-04 Bristol-Meyers Squibb Company 7-oxypropylsulfonamido-imidazo[4,5-b]quinolin-2-ones
US5348960A (en) * 1992-04-03 1994-09-20 Bristol-Myers Squibb Company Imidazo[4,5-b]quinolinyl oxy alkyl tetrazolyl piperidine derivatives
US5552267A (en) * 1992-04-03 1996-09-03 The Trustees Of Columbia University In The City Of New York Solution for prolonged organ preservation
US5196428A (en) * 1992-04-03 1993-03-23 Bristol-Myers Squibb Company Imidazo[4,5-b]qinolinyl oxy alkyl ureas
TW593317B (en) * 1993-06-21 2004-06-21 Janssen Pharmaceutica Nv Positive cardiac inotropic and lusitropic pyrroloquinolinone derivatives
EP0707585A1 (en) * 1993-07-06 1996-04-24 Pfizer Inc. Bicyclic tetrahydro pyrazolopyridines
TW530047B (en) * 1994-06-08 2003-05-01 Pfizer Corticotropin releasing factor antagonists
US6664264B2 (en) * 2000-12-08 2003-12-16 3M Innovative Properties Company Thioether substituted imidazoquinolines
AU2004266658A1 (en) 2003-08-12 2005-03-03 3M Innovative Properties Company Hydroxylamine substituted imidazo-containing compounds
BRPI0413998A (pt) 2003-08-27 2006-11-07 3M Innovative Properties Co imidazoquinolinas arilóxi e arilalquilenóxi substituìdas
US20050054665A1 (en) 2003-09-05 2005-03-10 3M Innovative Properties Company Treatment for CD5+ B cell lymphoma
BRPI0414856A (pt) 2003-10-03 2006-11-21 3M Innovative Properties Co imidazoquinolinas alcóxi-substituìdas
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
WO2005048933A2 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Oxime substituted imidazo ring compounds
CA2545825A1 (en) * 2003-11-14 2005-06-02 3M Innovative Properties Company Hydroxylamine substituted imidazo ring compounds
CA2547020C (en) 2003-11-25 2014-03-25 3M Innovative Properties Company 1h-imidazo[4,5-c]pyridine-4-amine derivatives as immune response modifier
WO2005066170A1 (en) 2003-12-29 2005-07-21 3M Innovative Properties Company Arylalkenyl and arylalkynyl substituted imidazoquinolines
AU2004312508A1 (en) 2003-12-30 2005-07-21 3M Innovative Properties Company Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides
TW200612932A (en) 2004-03-24 2006-05-01 3M Innovative Properties Co Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
WO2005123080A2 (en) 2004-06-15 2005-12-29 3M Innovative Properties Company Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
US7897609B2 (en) 2004-06-18 2011-03-01 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
US7915281B2 (en) 2004-06-18 2011-03-29 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
WO2006009826A1 (en) 2004-06-18 2006-01-26 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
CA2580343A1 (en) * 2004-09-14 2006-03-23 Novartis Vaccines And Diagnostics, Inc. Imidazoquinoline compounds
US8034938B2 (en) 2004-12-30 2011-10-11 3M Innovative Properties Company Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
AU2005322898B2 (en) 2004-12-30 2011-11-24 3M Innovative Properties Company Chiral fused (1,2)imidazo(4,5-c) ring compounds
US9248127B2 (en) 2005-02-04 2016-02-02 3M Innovative Properties Company Aqueous gel formulations containing immune response modifiers
US7968563B2 (en) 2005-02-11 2011-06-28 3M Innovative Properties Company Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
CA2602683A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. Pyrazolopyridine-1,4-diamines and analogs thereof
WO2006107851A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
WO2008008432A2 (en) 2006-07-12 2008-01-17 Coley Pharmaceutical Group, Inc. Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods
US8227603B2 (en) 2006-08-01 2012-07-24 Cytokinetics, Inc. Modulating skeletal muscle
US8299248B2 (en) 2006-08-02 2012-10-30 Cytokinetics, Incorporated Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use
PT2583970E (pt) 2006-08-02 2016-02-08 Cytokinetics Inc Certas entidades químicas, composições e métodos compreendendo imidazopirimidinas
EP2139478A4 (en) * 2007-03-30 2010-05-05 Cytokinetics Inc CHEMICAL ENTITIES, COMPOSITIONS AND METHODS
EA201791043A1 (ru) 2011-07-13 2017-09-29 Сайтокинетикс, Инк. Комбинированная терапия бокового амиотрофического склероза
CN120265631A (zh) * 2023-01-13 2025-07-04 上海超阳药业有限公司 喹啉酮化合物和萘啶酮化合物及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932407A (en) * 1973-11-19 1976-01-13 Bristol-Myers Company Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones

Also Published As

Publication number Publication date
CN1016175B (zh) 1992-04-08
HK64492A (en) 1992-09-04
IT8620206A0 (it) 1986-04-24
KR940000828B1 (ko) 1994-02-02
GB2174987A (en) 1986-11-19
AT390257B (de) 1990-04-10
ES557552A0 (es) 1988-07-16
FI861684A0 (fi) 1986-04-22
ATA112186A (de) 1989-09-15
DK165248C (da) 1993-03-22
DK81091A (da) 1991-05-01
NO163406C (no) 1990-05-23
NZ215885A (en) 1989-04-26
SU1450746A3 (ru) 1989-01-07
SE461468B (sv) 1990-02-19
AU5641386A (en) 1986-10-30
YU46054B (sh) 1992-12-21
ES554336A0 (es) 1987-10-01
GR861086B (en) 1986-09-01
DK190986D0 (da) 1986-04-24
GB2174987B (en) 1989-08-02
CH675722A5 (da) 1990-10-31
SU1560056A3 (ru) 1990-04-23
ES557551A0 (es) 1988-02-16
DK190986A (da) 1986-10-26
NO861617L (no) 1986-10-27
BE904671A (fr) 1986-10-24
NO163406B (no) 1990-02-12
OA08242A (en) 1987-10-30
DK165249B (da) 1992-10-26
SG29092G (en) 1992-05-15
AU592983B2 (en) 1990-02-01
ES8802521A1 (es) 1988-07-16
ES8708229A1 (es) 1987-10-01
FR2581065B1 (fr) 1990-02-02
SE8601907D0 (sv) 1986-04-24
CY1641A (en) 1992-11-06
DK165248B (da) 1992-10-26
SE8601907L (sv) 1986-10-26
IT1215651B (it) 1990-02-22
FI861684L (fi) 1986-10-26
FR2581065A1 (fr) 1986-10-31
CN86102747A (zh) 1987-02-04
PT82460B (pt) 1988-11-30
FI83316B (fi) 1991-03-15
DK80291A (da) 1991-04-30
PT82460A (en) 1986-05-01
HUT42089A (en) 1987-06-29
KR860008177A (ko) 1986-11-12
FI83316C (fi) 1991-06-25
EG18104A (en) 1992-09-30
DK164868B (da) 1992-08-31
DK80291D0 (da) 1991-04-30
US4668686A (en) 1987-05-26
GB8610037D0 (en) 1986-05-29
MY102086A (en) 1992-03-31
ES8801829A1 (es) 1988-02-16
IL78581A0 (en) 1986-08-31
DK164868C (da) 1993-01-11
DE3614132A1 (de) 1986-11-27
NL8601053A (nl) 1986-11-17
LU86406A1 (fr) 1986-11-05
SU1470192A3 (ru) 1989-03-30
DK81091D0 (da) 1991-05-01
YU116787A (en) 1988-04-30
HU195813B (en) 1988-07-28
CA1298836C (en) 1992-04-14

Similar Documents

Publication Publication Date Title
DK165249C (da) Imidazooe4,5-baaquinolin-2-thionderivater samt fremgangsmaade til fremstilling deraf
DK147488A (da) Benzoxazolderivat samt fremgangsmaade til fremstilling deraf
DK74087A (da) Indolizinderivater og fremgangsmaade til fremstilling deraf samt midler indeholdende derivaterne
NO860190L (no) Peptid-derivater og fremgangsmaate for fremstilling derav.
DK528689A (da) Quinolinderivater samt fremgangsmaade til fremstilling deraf
NO863608L (no) Fremgangsmaate for fremstilling av benzimidazolderivater.
NO862860L (no) Fremgangsmaate for fremstilling av poly-4-aminopyrrole-2-karboksamidoderivater.
DK642588A (da) Indanderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
DK346889D0 (da) Heteropolysaccharid bm07, fremgangsmaade til fremstilling deraf samt anvendelse deraf
DK163584C (da) 7-amino-3-propenylcephalosporinsyrederivater samt fremgangsmaade til fremstilling deraf
NO161402C (no) Prosjektildannende innlegg samt framgangsmaate for framstilling av dette.
DK161086A (da) Nitrofuranderivater samt fremgangsmaade til fremstilling og anvendelse deraf
ES551410A0 (es) Procedimiento de preparar derivados rodaninicos.
DK115685D0 (da) Prespap samt fremgangsmaade til fremstilling deraf
DK113591A (da) 3-oe2-chlorethylaaquinazolin-2,4-dioner samt fremgangsmaade til fremstilling deraf
DK548086D0 (da) Nitroanthracycliner, fremgangsmaade til deres fremstilling samt deres anvendelse
NO875230L (no) Imidazolderivater, samt fremgangsmaate for fremstilling derav.
DK404587D0 (da) 5-deoxy-5-flourkanamycin b-derivater samt fremgangsmaader til fremstilling deraf
DK504786A (da) Peptidforbindelser samt fremgangsmaade til fremstilling heraf
DK191684D0 (da) Hydroxylerede diphenylazomethinderivater samt fremgangsmaade til fremstilling deraf
DK160827C (da) Pteridinderivater, fremgangsmaade til fremstilling heraf samt farmaceutisk praeparat
DK354789A (da) Alkenyltetrazolderivater samt fremgangsmaade til fremstilling deraf
DK412386A (da) Erythromycin-derivater samt fremgangsmaade til fremstilling deraf
DK559185D0 (da) Sulfamoylbenzoesyrederivater samt fremgangsmaade til fremstilling deraf
DK108085A (da) Nye oxadiazolylimidazobenzodiazepinderivater samt fremgangsmaade til fremstilling heraf

Legal Events

Date Code Title Description
PBP Patent lapsed